Explorer les evidences

No patient was co-infected with HBV and HCV.

Camerounhépatite B · hépatite Cpublié 2009HIV MedicineOpenAlexdocument de 5 observations

142 isolatesNo major mutations associated with resistance to nucleoside reverse transcriptase inhibitors (NRTIs) or protease inhibitors were detected in 142 HIV-1 isolates from antiretroviral-naive patients.

CamerounVIH/sidapublié 2000Journal of Clinical MicrobiologyOpenAlexdocument de 19 observations

8 yearsPatients had a mean known duration of diabetes of 8.0 years.

Cameroundiabète (non précisé)publié 2012Diabetes research and clinical practiceeurope_pmcdocument de 4 observations

81,1 %On day 3, 77 out of 95 participants (81.1%) on hydroxychloroquine-azithromycin were asymptomatic.

CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations

10,4 %Among ART initiators with no prior exposure to antiretrovirals in Cameroon, pretreatment HIV drug resistance (PDR) prevalence was 10.4% (95% CI 4.7%–21.5%).

CamerounVIH/sidaobservé 2015publié 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument de 12 observationsDOI 10.1093/jac/dky221

In this population, the cumulative incidence of type 1 diabetes in offspring of type 1 diabetic men and women was not significantly different.

Cameroundiabète de type 1publié 2003Diabetes & metabolismeurope_pmcdocument de 5 observations

16,7 %Total diabetes prevalence in Saudi Arabia was estimated at 16.7% in 2011 by the IDF.

Cameroundiabète (non précisé)observé 2011publié 2014Diabetes research and clinical practiceeurope_pmcdocument de 7 observations

61,9 %Seventy (61.9%) of the patients with diabetes had poor glycemic control.

Cameroundiabète (non précisé)observé 2019publié 2022The Pan African medical journaleurope_pmcdocument de 10 observations

10,7 %Among 503 patients with diabetes admitted at Yaoundé Central Hospital from November 1999 to October 2002, 54 (10.7%) had foot ulcers.

Cameroundiabète (non précisé)observé November 1999 to October 2002publié 2006Journal of wound careeurope_pmcdocument de 8 observations

10 800 000 deathsIn 2010, 10.8 million deaths from cardiovascular diseases, chronic kidney disease, and diabetes were attributable to the combined effect of high blood pressure, high BMI, high glucose, and high cholesterol.

Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0

-33 mmol/molThere was a significant reduction in HbA1c in the intervention group of -33 mmol/mol (-3.0%) compared with controls of -14 mmol/mol (-1.3%).

Cameroundiabète de type 2publié 2015Diabetic medicine : a journal of the British Diabetic Associationeurope_pmc

1,8 genotypes_per_infectionThe multiplicity of infection (MOI) was 1.80 in Tibati.

CamerounpaludismeHAL · Unilimdocument de 106 observations

99 %Almost 99% of malaria cases were due to Plasmodium falciparum in 2023.

Camerounpaludismeobservé 2023HAL · Unilimdocument de 106 observations

2 %The prevalence of the 333E substitution in reverse transcriptase sequences was 2% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

1,2 %In Monatélé Health Area, the prevalence of epilepsy recorded by the research team was 1.20%.

CamerounépilepsieHAL · Unilimdocument de 53 observations

All patients in the spironolactone group achieved blood pressure control below 130/80 mmHg after one month of treatment.

Cameroundiabète de type 2 · resistant hypertensionpublié 2016BMC research noteseurope_pmcdocument de 5 observations

4,8 %The prevalence of ectopic beats among type 2 diabetes patients in Cameroon was 4.8%.

Cameroundiabète de type 2 · ectopic beatspublié 2012Cardiovascular journal of Africaeurope_pmcdocument de 11 observations

39,1 %The prevalence of preoperative malnutrition according to the Buzby score was 39.1%.

Camerounmalnutritionobservé 2014publié 2017BMC research noteseurope_pmcdocument de 6 observations

2 409 patientsAmong 2409 sickle cell disease patients in the CADRE cohort from Ivory Coast, Cameroon, and Mali, 1751 had the SS-Sβ0 phenotype and 658 had the SC-Sβ+ phenotype.

Cameroun · Côte d'Ivoire · Malidrépanocytosepublié 2015BloodOpenAlexdocument de 16 observations

794 cases794 individuals were identified as suspected cases of epilepsy in the 190 communities surveyed in Cameroon.

Camerounépilepsieobservé 2020HAL · Unilimdocument de 53 observations

7,54 timesPersons with diagnosed diabetes had 7.54 times more outpatient visits than matched comparison subjects without diabetes in Cameroon, Mali, Tanzania and South Africa during 2008–2009.

Afrique du Sud · Cameroun · Mali · Tanzaniediabète (non précisé)observé 2008–2009publié 2014PloS oneeurope_pmcdocument de 3 observations

21,8 %The prevalence of chronic venous disease was 21.8% in Cameroon.

Camerounchronic venous diseaseobservé 2020-2021publié 2024Phlebologyeurope_pmcdocument de 9 observations

60 %Overall, more than 60% of the isolates had multiclonal infections.

CamerounpaludismeHAL · Unilimdocument de 106 observations

5,9 %GDM prevalence was 5.9% using WHO 1999 criteria in a Cameroonian population.

Cameroundiabète gestationnelpublié 2023Frontiers in clinical diabetes and healthcareeurope_pmcdocument de 9 observationsDOI 10.3389/fcdhc.2023.1272333

1,05 odds_ratioThe adjusted odds ratio for prevalent screen-detected diabetes with each standard deviation higher waist-hip-ratio was 1.05 (95% CI: 1.00–1.16).

Camerounscreen-detected diabetesobservé 2006publié 2015Diabetes research and clinical practiceeurope_pmcdocument de 5 observations